[PDF] Global Supply Chains In The Pharmaceutical Industry eBook

Author : Nozari, Hamed
Publisher : IGI Global
Page : 399 pages
File Size : 18,16 MB
Release : 2018-11-09
Category : Business & Economics
ISBN : 1522559221

GET BOOK

In a rapidly growing global economy, where there is a constant emergence of new business models and dynamic changes to the business ecosystem, there is a need for the integration of traditional, new, and hybrid concepts in the complex structure of supply chain management. Within the fast-paced pharmaceutical industry, product strategy, life cycles, and distribution must maintain the highest level of agility. Therefore, organizations need strong supply chain capabilities to profitably compete in the marketplace. Global Supply Chains in the Pharmaceutical Industry provides innovative insights into the efforts needed to build and maintain a strong supply chain network in order to achieve efficient fulfillment of demand, drive outstanding customer value, enhance organizational responsiveness, and build network resiliency. This publication is designed for supply chain managers, policymakers, researchers, academicians, and students, and covers topics centered on economic cycles, sustainable development, and new forces in the global economy.

Author : Hamed Nozari
Publisher : Business Science Reference
Page : 0 pages
File Size : 36,93 MB
Release : 2018-11-09
Category : Business & Economics
ISBN : 9781522559238

GET BOOK

"This book presents a complex view of supply chain management in global pharmaceutical industry, theory and empirical research findings. It also provides the resources necessary for policy makers and managers to adopt and implement supply chain in developing nations across the globe"--

Author : Hamed Nozari
Publisher : Business Science Reference
Page : 404 pages
File Size : 24,44 MB
Release : 2018-12-18
Category :
ISBN : 9781522587057

GET BOOK

"This book presents a complex view of supply chain management in global pharmaceutical industry, theory and empirical research findings. It also provides the resources necessary for policy makers and managers to adopt and implement supply chain in developing nations across the globe"--

Author : Hedley Rees
Publisher : John Wiley & Sons
Page : 458 pages
File Size : 36,98 MB
Release : 2011-04-06
Category : Medical
ISBN : 0470922842

GET BOOK

This book bridges the gap between practitioners of supply-chain management and pharmaceutical industry experts. It aims to help both these groups understand the different worlds they live in and how to jointly contribute to meaningful improvements in supply-chains within the globally important pharmaceutical sector. Scientific and technical staff must work closely with supply-chain practitioners and other relevant parties to help secure responsive, cost effective and risk mitigated supply chains to compete on a world stage. This should not wait until a drug has been registered, but should start as early as possible in the development process and before registration or clinical trials. The author suggests that CMC (chemistry manufacturing controls) drug development must reset the line of sight – from supply of drug to the clinic and gaining a registration, to the building of a patient value stream. Capable processes and suppliers, streamlined logistics, flexible plant and equipment, shorter cycle times, effective flow of information and reduced waste. All these factors can and should be addressed at the CMC development stage.

Author : Ana Paula Barbosa-Povoa
Publisher : Springer
Page : 269 pages
File Size : 49,50 MB
Release : 2019-06-01
Category : Medical
ISBN : 3030153983

GET BOOK

This book provides an insight of relevant case studies and updated practices in “PharmaceuticalSupply Chains” (PharmSC) while addressing the most relevant topics within the COST Action “Medicines Shortages” (CA15105).The volume focuses on the most recent developments in the design, planning and scheduling ofPharmSC, broadening from the suppliers’ selection to the impact on patients and healthcaresystems, addressing uncertainty and risk mitigation, and computational issues. It is directed at MSc/PhD students and young researchers (Post-Docs) in Pharmaceutics/Pharmaceutical sciences, Engineering fields, Economics/Management, as well as pharmaceutical decision makers, managers, and practitioners, and advanced readers demanding a fresh approach to decision making for PharmSC. The contributed chapters are associated with the homonymous COST Training Schools (TS), and the book creates a better understanding of the Action “Medicines Shortages” challenges and opportunities.

Author : Robert Handfield
Publisher : CRC Press
Page : 275 pages
File Size : 21,4 MB
Release : 2012-06-06
Category : Business & Economics
ISBN : 1466568046

GET BOOK

A comprehensive exploration of the massive changes in the biopharmaceutical supply chain that have occurred during the past 10 years, and predicted future trends, Biopharmaceutical Supply Chains: Distribution, Regulatory, Systems and Structural Changes Ahead documents the specific impacts of these changes for key players in the supply chain. Based

Author : Rob Whewell
Publisher : CRC Press
Page : 254 pages
File Size : 46,18 MB
Release : 2016-04-01
Category : Business & Economics
ISBN : 1317048334

GET BOOK

The pharmaceutical and healthcare industry is hugely complex because it involves so many markets, products, processes and intermediaries. It is also heavily regulated, global, and used by everyone at some stage in their life. No wonder the supply chain for delivery of healthcare services is often fragmented and understood only in discrete sections. Changes in one area impact upon the others, and environmental factors such as pricing, regulatory change or actions by competitors impact the whole supply chain in ways that are not easily understood or managed. Accelerating technology, the commoditization of healthcare, increasing demands from ageing populations all influence the approach that suppliers of pharmaceutical products and services worldwide need to take if they are to design and manage an effective supply chain that will be capable of: exploiting their intellectual property in a sustainable way; providing safe and continuous provision of drugs or devices; and sustaining with resilience, yet still be flexible and cost efficient. Supply Chain in the Pharmaceutical Industry offers the basis for organizations to develop their own blueprint for managing the opportunities and threats to the pharmaceutical supply chain. Using examples from companies and markets across the world Rob Whewell offers a very vivid picture of the developing trends for pharmaceutical companies; the customers and markets they serve and points to some of the elements that underpin sustainable pharmaceutical strategies. The current global banking and financial crisis illustrates the important role played by regulation. The healthcare industry is similar in scope, and complexity, yet the implications of error are worse - life threatening. This review of key industry parameters will provide senior executives in the industry and policy makers in healthcare with a broad perspective of the issues and illustrates an understanding of the task at hand.

Author : Hanna Kattilakoski
Publisher : GRIN Verlag
Page : 38 pages
File Size : 34,5 MB
Release : 2020-07-07
Category : Business & Economics
ISBN : 3346197255

GET BOOK

Academic Paper from the year 2017 in the subject Business economics - Supply, Production, Logistics, grade: 90.0, Cologne Business School Köln, language: English, abstract: The purpose of this paper is to investigate the pharmaceutical industry in terms of sustainable supply chains and comparing this to the Gap Frame Framework. Two companies, Bayer and Roche, will be analyzed to provide a look into current practice. The Gap Frame is a framework that translates the Sustainable Development Goals (SDG) into nationally relevant issues and indicators for business. The aim of this framework is to aid companies in shifting their behavior and strategic perspectives by showing both the inside-out and outside-in perspectives of environmental challenges a country is facing. By using the Gap Frame from an outside-in perspective, businesses can address the challenges highlighted by the circle model and use an integrative approach to better align their operations in order to reach the SDGs. The four sustainability dimensions in the circle model are Planet, Society, Economy and Governance. The focus of this research will be on the economy dimension, which includes several issues: Innovation, Employment, Resource Use, Sustainable Production, Sustainable Consumption.

Author : Moritz Schümann
Publisher :
Page : 65 pages
File Size : 32,33 MB
Release : 2020
Category :
ISBN :

GET BOOK

The pharmaceutical industry must handle the supply side cost pressures of the day for profitability. However, increasing efficiencies along its supply chain through company mergers, the consolidation of production sites and the relocation of manufacturing create increasing complexity. It is no coincidence that this has led to an increased dependency on China and India. The COVID-19 pandemic of 2020 is a large threat to pharmaceutical production, transportation, storage, supply and distribution. In recent years, worldwide supply shortages and stockouts for medicinal products have risen, so the COVID-19 pandemic intensifies the potential monetary and social consequences of drug shortages. A thorough understanding of pharmaceutical supply chain structures and the risks in supply chains and their management provide the fundamentals to assess the impact of the pandemic. The pharmaceutical industry is characterized by above-average stock levels to maintain its constant readiness to deliver to society. The German BfArM drug supply database and media reports allow a local analysis of this readiness during the pandemic. Bottlenecks from patient stockpiling and increased occupancy in intensive care units are evident, but the German COVID-19 pandemic has not led to significant supply shortages, indicating that above-average stock levels have ameliorated the e↵ects of the Chinese production cessation in early 2020. It remains unclear whether the consequences of production losses can be completely absorbed by the prevailing stockpiles particularly if the pandemic continues. Up to mid-2020, the pandemic impact has been minimal for the pharmaceutical industry. However, the industry must begin to include risk management strategies in its assessment of efficiency, by considering pandemic scenarios with higher death rates, more dependency on pharmaceuticals and longer periods of quarantine. For affected governments and other companies worldwide, it is clear that more transparency and communication along globalized supply chains is required in order to successfully manage present and future risks.

Author : Kumar, Akhilesh
Publisher : IGI Global
Page : 378 pages
File Size : 43,50 MB
Release : 2017-12-15
Category : Business & Economics
ISBN : 1522530576

GET BOOK

The proper understanding and managing of project risks and uncertainties is crucial to any organization. It is paramount that all phases of project development and execution are monitored to avoid poor project results from meager economics, overspending, and reputation. Supply Chain Management Strategies and Risk Assessment in Retail Environments is a comprehensive reference source for the latest scholarly material on effectively managing risk factors and implementing the latest supply management strategies in retail environments. Featuring coverage on relevant topics such as omni-channel retail, green supply chain, and customer loyalty, this book is geared toward academicians, researchers, and students seeking current research on the challenges and opportunities available in the realm of retail and the flow of materials, information, and finances between companies and consumers.